Intra-observer agreement in single and joint double readings of contrast-enhanced breast MRI screening for women with high genetic breast cancer risks
Journal Title: Journal of Cancer Research & Therapy - Year 2013, Vol 1, Issue 2
Abstract
Objectives: To examine intra-observer reliability (IR) for lesion detection on contrast-enhanced breast magnetic resonance images (MRI) for screening women at high risk of breast cancer in single and joint double readings, without case selection. Methods: Contrast-enhanced breast MRIs were interpreted twice by the same independent reader and twice in joint readings. IR was assessed for lesion detection, normal MRI identification, mass, non-mass like enhancements (NMLE) and focus characterisation, and BI-RADS assessment. Results: MRI examinations for 124 breasts, 65 women (mean age 43.4y) were retrospectively reviewed with 110 lesions identified. Abnormal BIRADS (3-5) classifications were found for 52.3% in single readings and 58.5% in joint readings. Seven biopsies were performed for 4 histologically confirmed cancers. IR for BI-RADS classifications was good for single (0.63, 95% CI: 0.49-0.77), and joint readings (0.77, 95% CI: 0.61-0.93). IR for background parenchymal enhancement (BPE) was moderate across single (0.53, 95% CI: 0.40-0.65) and joint readings (0.44, 95% CI: 0.33-0.56). IR for BI-RADS category according to each enhancement was poor for single (0.27, 95% CI: 0.10-0.44), and higher for joint readings, (0.58, 95% CI: 0.43-0.72). Conclusions: IR in BI-RADS breast assessments or BI-RADS lesion assessments are better with joint reading in screening for women with high genetic risks, in particular for abnormal MRI (BI-RADS 3, 4 and 5).
Authors and Affiliations
Hugo C, Hurtevent G, Ferron S, Boisserie-Lacroix M, Longy M, Floquet A, Brouste V, Asad-Syed M
Keywords
Related Articles
- EP ID EP550690
- DOI 10.14312/2052-4994.2013-14
- Views 75
- Downloads 0
Capecitabine induced hypertriglyceridaemia: An underreported and potentially severe side effect
A 57 year-old-woman, with no previous history of dyslipedemia, developed severe hypertriglyceridemia while being treated with capecitabine for metastatic breast cancer. Capecitabine was not discontinued and serum triglyc...
Evaluation of tissue 5´-Nucleotidase as tumor marker in breast and brain tumors using receiver operating characteristic curve
The pursuit of the ideal tumor marker has generated many testes for using in the diagnosis and management of cancer. Several of which are now widely available. The objective of the current study was to evaluate 5´-NT act...
Advance care planning in patients with brain tumours: A prospective cohort study
Objectives: To assess and understand the awareness and experience of brain tumour (BT) patients in discussing Advance Care Planning (ACP), to identify main symptoms experienced, physical and functional status perceived q...
Malignant solitary fibrous tumor of the sacrum: A case report
The solitary fibrous tumor (SFT) is a rare ubiquitous mesenchymal neoplasm of fibroblastic type, which shows a prominent hemangiopericytoma-like branching vascular pattern. Approximately 40% of solitary fibrous tumors ar...
Evaluation of serum big endothelin-1 for the diagnosis and prediction of disease recurrence in breast cancer patients
Big endothelin-1 (big ET-1) is the biological precursor of endothelin-1 (ET-1) and it is known as an indicator for the degree of activation of endothelin system. Therefore, this study was designed to investigate the seru...